Portal:Disease/BlauBookPathways
From WikiPathways
(Difference between revisions)
Current revision (13:55, 8 January 2020) (view source) |
|||
| Line 36: | Line 36: | ||
* [[Pathway:WP4224]] - Chapter 41 "Purine Disorders" | * [[Pathway:WP4224]] - Chapter 41 "Purine Disorders" | ||
* [[Pathway:WP4225]] - Chapter 41 "Pyrimidine Disorders" | * [[Pathway:WP4225]] - Chapter 41 "Pyrimidine Disorders" | ||
| + | |||
| + | * [[Pathway:WP4522]] - Chapter 43 "Metabolic pathway of LDL, HDL and TG, including diseases" | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
| Line 43: | Line 45: | ||
|width=100px|{{#pwImage:Pathway:WP4224|250px||Purine Disorders}} | |width=100px|{{#pwImage:Pathway:WP4224|250px||Purine Disorders}} | ||
|width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}} | |width=100px|{{#pwImage:Pathway:WP4225|250px||Pyrimidine Disorders}} | ||
| + | |width=60px|{{#pwImage:Pathway:WP4522|230px||Metabolic pathway of LDL, HDL and TG, including diseases}} | ||
|} | |} | ||
| Line 52: | Line 55: | ||
* [[Pathway:WP4524]] - Chapter 37 "The alternative pathway of fetal androgen synthesis, including diseases" | * [[Pathway:WP4524]] - Chapter 37 "The alternative pathway of fetal androgen synthesis, including diseases" | ||
* [[Pathway:WP4518]] - Chapter 42 "Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases" | * [[Pathway:WP4518]] - Chapter 42 "Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases" | ||
| - | + | ||
{| style="margin: 10px" | {| style="margin: 10px" | ||
| Line 60: | Line 63: | ||
|width=60px|{{#pwImage:Pathway:WP4524|230px||The alternative pathway of fetal androgen synthesis, including diseases}} | |width=60px|{{#pwImage:Pathway:WP4524|230px||The alternative pathway of fetal androgen synthesis, including diseases}} | ||
|width=60px|{{#pwImage:Pathway:WP4518|230px||Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases}} | |width=60px|{{#pwImage:Pathway:WP4518|230px||Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases}} | ||
| - | |||
|} | |} | ||
Current revision
- Pathway:WP4156 - Chapter 1 "Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism"
- Pathway:WP4506 - Chapter 2 "Tyrosine Metabolism"
- Pathway:WP4292 - Chapter 3 "Sulphur Amino Acids"
- Pathway:WP4259 - Chapter 10 "Disorders of Folate Metabolism and Transport"
- Pathway:WP4288 - Chapter 10 "MTHFR deficiency (additional pathway)"
|
Image does not exist Disorders of Phenylalanine and Tetrahydrobiopterin (BH4) Metabolism |
Image does not exist Tyrosine Metabolism |
Image does not exist Sulphur Amino Acids |
Image does not exist Disorders of Folate Metabolism and Transport |
Image does not exist MTHFR deficiency (additonal pathway) |
- Pathway:WP4228 - Chapter 11 "Vitamine B6-Dependent and Responsive Disorders"
- Pathway:WP4507 - Chapter 12 "Molybdenum (Moco) cofactor biosynthesis"
- Pathway:WP4504 - Chapter 12 "Cysteine and Methionine catabolism"
- Pathway:WP4271 - Chapter 13 "Vitamin B12 Disorders"
- Pathway:WP4297 - Chapter 15 "Thiamine Disorders"
|
Image does not exist Vitamine B6-Dependent and Responsive Disorders |
Image does not exist Molybdenum (Moco) cofactor biosynthesis |
Image does not exist Cysteine and Methionine catabolism |
Image does not exist Vitamin B12 Disorders |
Image does not exist Thiamine Disorders |
- Pathway:WP4236 - Chapter 20 "Disorders of the Krebs Cycle"
- Pathway:WP4153 - Chapter 25 "Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses (Sphingolipid degradation)"
- Pathway:WP4220 - Chapter 31 "Neurotransmitter Disorders"
- Pathway:WP4224 - Chapter 41 "Purine Disorders"
- Pathway:WP4225 - Chapter 41 "Pyrimidine Disorders"
- Pathway:WP4522 - Chapter 43 "Metabolic pathway of LDL, HDL and TG, including diseases"
|
Image does not exist Disorders of the Krebs Cycle |
Image does not exist Lysosomal Storage Disorders Including Neuronal Ceroid Lipofuscinoses (Sphingolipid degradation) |
Image does not exist Neurotransmitter Disorders |
Image does not exist Purine Disorders |
Image does not exist Pyrimidine Disorders |
Image does not exist Metabolic pathway of LDL, HDL and TG, including diseases |
Pathways with kinetics data [coming soon!].
- Pathway:WP4519 - Chapter 8 "Cerebral Organic Acidurias, including diseases"
- Pathway:WP4521 - Chapter 30 "Glycosylation and related congenital defects."
- Pathway:WP4523 - Chapter 37 "Classical pathway of steroidogenesis, including diseases"
- Pathway:WP4524 - Chapter 37 "The alternative pathway of fetal androgen synthesis, including diseases"
- Pathway:WP4518 - Chapter 42 "Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases"
|
Image does not exist Cerebral Organic Acidurias, including diseases |
Image does not exist Glycosylation and related congenital defects. |
Image does not exist Classical pathway of steroidogenesis, including diseases |
Image does not exist The alternative pathway of fetal androgen synthesis, including diseases |
Image does not exist Gamma-Glutamyl Cycle for the biosynthesis and degradation of glutathione, including diseases |
